ArticleRSC advances2025
Novel lead-free bismuth-based perovskite-like (BrC
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lead-free organic-inorganic hybrid perovskites have attracted increasing attention owing to their advantages of reduced toxicity, photo-detectability, switchable dielectric device application, ferroelectric properties and distinctive optical characteristics. Despite their promising features, the chemical engineering of hybrid perovskites remains a challenge, as identifying the appropriate strategies is essential to achieve the desired properties such as controlled bandgap energy and phase transition behaviours. Numerous approaches have been explored to optimize these characteristics. In this study, we employed halogenation of the organic component as a targeted strategy to enhance the stability and performance of hybrid perovskite materials. This approach enabled the successful synthesis of a non-centrosymmetric halobismuthate (BrC
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.